二维剪切波弹性成像联合传播图与衰减成像对非酒精性脂肪性肝病的诊断效能
本研究纳入232例参与者(164例NAFLD患者和68例健康对照),以振动控制瞬时弹性成像联合受控衰减参数为参考,评估二维剪切波弹性成像(2D-SWE)与衰减成像(ATI)定量肝纤维化和脂肪变性的效能,发现两者与参考方法显著相关,并确定了NAFLD特异性诊断阈值。
要点
- 2D-SWE诊断F≥2、F≥3、F=4的阈值分别为7.9、10、11.4 kPa,AUC均≥0.91。
- ATI诊断S1、S2、S3的阈值分别为0.73、0.76、0.80 dB/cm/MHz。
- 按Baveno VI标准,诊断肝硬化阈值15.5 kPa(AUC=0.94),排除代偿期进展性慢性肝病阈值9.2 kPa(AUC=0.92)。
核心结论
- 2D-SWE联合传播图与ATI可可靠定量NAFLD患者的肝纤维化和脂肪变性。
研究设计与样本
- 前瞻性纳入连续NAFLD患者和健康志愿者共232例(NAFLD组164例,健康对照组68例),女性51.7%、男性49.3%,平均年龄54.2±15.2岁,平均BMI 29.4±6.5 kg/m2。
- 以振动控制瞬时弹性成像联合受控衰减参数为参考标准,研究采用2D-SWE联合传播图和ATI作为评估方法。
诊断标准与关键数值
- NAFLD特异性2D-SWE肝硬度阈值:F≥2为7.9 kPa(AUC=0.91),F≥3为10 kPa(AUC=0.92),F=4为11.4 kPa(AUC=0.95)。
- ATI脂肪变性阈值:S1为0.73 dB/cm/MHz(AUC=0.86),S2为0.76 dB/cm/MHz(AUC=0.86),S3为0.80 dB/cm/MHz(AUC=0.83)。
- 按Baveno VI标准,2D-SWE诊断肝硬化最佳阈值为15.5 kPa(AUC=0.94),排除代偿期进展性慢性肝病阈值为9.2 kPa(AUC=0.92)。
临床应用与阅片要点
- 在NAFLD患者中可采用上述2D-SWE和ATI阈值进行纤维化分期和脂肪变性分级,辅助临床决策。
- 诊断肝硬化或排除代偿期进展性慢性肝病时可参考Baveno VI相关阈值。
局限性
- 本研究以振动控制瞬时弹性成像联合受控衰减参数为参考标准,而非肝活检。
- 研究纳入连续NAFLD患者和健康志愿者,可能影响结果的外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
We aimed to investigate the diagnostic performance of new 2-D shear-wave elastography (SWE) with propagation maps and attenuation imaging (ATI) for quantification of fibrosis and steatosis in non-alcoholic fatty liver disease (NAFLD). Consecutive patients with NAFLD and healthy volunteers underwent liver stiffness measurement and steatosis quantification by means of vibration-controlled transient elastography coupled with the controlled attenuation parameter as the reference and by 2-D shear-wave elastography (2-D-SWE) with propagation maps and ATI as the investigational methods. We included 232 participants (164 in the NAFLD group and 68 in the healthy control group): 51.7%/49.3% women/men; mean age, 54.2 ± 15.2 y; mean body mass index, 29.4 ± 6.5 kg/m2. Significant correlations were found between 2-D-SWE and vibration-controlled transient elastography (r = 0.71, p < 0.0001) and between ATI and the controlled attenuation parameter (r = 0.72, p < 0.0001). NAFLD-specific 2-D-SWE liver stiffness measurement cutoffs were as follows-F ≥ 2: 7.9 kPa (area under the curve [AUC] = 0.91); F ≥ 3: 10 kPa (AUC = 0.92); and F = 4: 11.4 kPa (AUC = 0.95). For steatosis, the best cutoffs by ATI were as follows-S1 = 0.73 dB/cm/MHz (AUC = 0.86); S2 = 0.76 dB/cm/MHz (AUC = 0.86); and S3 = 0.80 dB/cm/MHz (AUC = 0.83). According to Baveno VI criteria, the optimal 2-D-SWE liver stiffness measurement for diagnosing liver cirrhosis is 15.5 kPa (AUC = 0.94), and for ruling out compensated advanced chronic liver disease it is 9.2 kPa (AUC = 0.92). To conclude, 2-D-SWE with propagation maps and ATI is reliable for quantification of liver fibrosis and steatosis in patients with NAFLD.
引用
- Podrug K, Sporea I, Lupusoru R, et al. Diagnostic Performance of 2-D Shear-Wave Elastography with Propagation Maps and Attenuation Imaging in Patients with Non-Alcoholic Fatty Liver Disease. Ultrasound Med Biol. 2021. PMID: 33985827. doi:10.1016/j.ultrasmedbio.2021.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。